BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 3369674)

  • 21. [Continuous treatment of asthma in children with theophylline retard].
    de Blic J; Scheinmann P; Benoist MR; Ruff F; Paupe J
    Arch Fr Pediatr; 1983 Feb; 40(2):123-7. PubMed ID: 6870478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sustained-release theophylline. Pharmacokinetic and therapeutic comparison of two preparations.
    Menendez R; Kelly HW; Howick J; McWilliams BC
    Am J Dis Child; 1983 May; 137(5):469-73. PubMed ID: 6846276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Delayed-action theophylline in the treatment children with chronic asthma. Results of our experience].
    Barberio G; Ruggeri C; Monego A; Pajno GB; Infortuna M; Santisi G; Picciolo A
    Minerva Pediatr; 1987 Jan; 39(1-2):59-63. PubMed ID: 3600560
    [No Abstract]   [Full Text] [Related]  

  • 24. A comparative study of theophylline in a slow-release 'sprinkle' format with a standard syrup preparation in young children with asthma.
    Dawson KP
    Pharmatherapeutica; 1986; 4(7):442-4. PubMed ID: 3960944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Administration of E-0686 granule, sustained-release theophylline, for asthmatic infants].
    Shinagawa Y; Ohta H; Kimura M; Iikura Y; Inui H; Umesato Y; Obata T; Nishikawa K; Uematsu F
    Arerugi; 1985 May; 34(5):329-36. PubMed ID: 4038083
    [No Abstract]   [Full Text] [Related]  

  • 26. Dose-effect relationship of a controlled release theophylline preparation in pre-school children.
    Duiverman EJ; Neijens HJ; Kerrebijn KF
    Br J Clin Pract Suppl; 1984; 35():55-6. PubMed ID: 6433962
    [No Abstract]   [Full Text] [Related]  

  • 27. Slow-release theophylline for the management of chronic asthma.
    Hendeles L; Weinberger M
    Singapore Med J; 1985 Feb; 26(1):83-90. PubMed ID: 3895446
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effectiveness and tolerance of the treatment of infantile bronchial asthma with soluble and delayed-action theophylline].
    Navarro M; Durán JA; Delgado JA; Serrano JS; González Hachero J
    An Esp Pediatr; 1987 Mar; 26(3):171-7. PubMed ID: 3579056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum drug fluctuations after administration of two sustained-release oral theophylline preparations in asthmatic children.
    Logvinoff MM; Weinstein DB; Watts MT; Seifert B
    Clin Ther; 1986; 8(2):175-80. PubMed ID: 3698064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Monitoring long-term therapy with theophylline preparations in children with asthma].
    Lindemann H; Bauer J; Schwandt HJ
    Monatsschr Kinderheilkd; 1985 Feb; 133(2):106-10. PubMed ID: 3920513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and pharmacodynamics of a short- and long-acting theophylline medication (Theolair and Theolair retard) in normals and asthmatics. Part II: Lung function and side effects.
    Utama I; Kreukniet J; Fokkens J; Serra R
    Int J Clin Pharmacol Ther Toxicol; 1983 Jun; 21(6):292-6. PubMed ID: 6885203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The clinical efficacy and characteristics of the effect of prolonged-action theophyllines on the external respiratory function and hemodynamics of bronchial asthma patients].
    Kakhnovskiĭ IM; Solomatin AS; Vdovina TI
    Ter Arkh; 1995; 67(1):48-51. PubMed ID: 7709358
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacokinetics of oral theophylline in asthmatic children: evaluation of a new preparation, "Theolair".
    Haddad ZH; Verma S; Soderberg-Warner M; Kalra V
    Ann Allergy; 1978 Mar; 40(3):167-70. PubMed ID: 637375
    [No Abstract]   [Full Text] [Related]  

  • 34. Sustained release theophylline for the forgetful asthmatic.
    Weinstein AG
    Ann Allergy; 1985 Oct; 55(4):563-7. PubMed ID: 4051262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioavailability, efficacy, and tolerance of two sustained-release theophylline dosage forms in adult patients with bronchial asthma.
    Trautlein JJ; Demers L; Esler V; Field E
    Clin Ther; 1981; 4(4):252-62. PubMed ID: 7332913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The usefulness of theophylline in the treatment of moderate-severe asthma].
    Cebollero Rivas P; Garisa Rocha R; Bazo Fernández E; Colás Sanz C; Duce Gracia F
    Rev Clin Esp; 1994 Apr; 194(4):288-90. PubMed ID: 8022993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison of two long-acting theophylline preparations in daily evening administration].
    Holzer R
    Wien Med Wochenschr; 1993; 143(2):37-42. PubMed ID: 8488685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of chronic asthma in children with a sustained-release preparation of theophylline in addition to beta 2-stimulating agents.
    Lönnerholm G; Foucard T; Lindström B
    Eur J Respir Dis Suppl; 1980; 109():95-7. PubMed ID: 6108230
    [No Abstract]   [Full Text] [Related]  

  • 39. A long-acting theophylline preparation.
    Practitioner; 1971 Feb; 206(232):283-6. PubMed ID: 5554568
    [No Abstract]   [Full Text] [Related]  

  • 40. [Compliance of children with bronchial asthma in long-term therapy with theophylline retard preparations].
    Köhler E; Sollich V; Schuster R
    Kinderarztl Prax; 1993 Aug; 61(6):207-10. PubMed ID: 8411846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.